Stock listing

NASDAQ:MRVI Maravai LifeSciences Holdings, Inc. Stock

Home listing (NASDAQ) of Maravai LifeSciences Holdings, Inc.

Follow Maravai LifeSciences Holdings, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MRVI

$6.98 USD -0.40 (-5.4%)

Close on Nov 20, 2026

Past year +104.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.91 – $7.17 USDNov 20, 2026
Volume
1.79M sharesNov 20, 2026
Market cap
$1.04B USDAt the close on Nov 20, 2026 · price × 149.0M shares outstanding
52-week range
$2.80 – $9.42 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$22.78M USDMedian day 2.37M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Maravai LifeSciences Holdings, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MRVI · Home$6.98 USD-0.40 (-5.4%)1,785,366$7.11$7.17$6.91$7.38Close on Nov 20, 2026
Frankfurt:MAR€6.35 EUR-0.15 (-2.3%)—€6.40€6.40€6.30€6.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MRVI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.98-0.40-5.4%$7.11$7.17$6.911,785,366
$7.38+0.10+1.4%$7.28$7.54$7.211,408,255
$7.28-0.12-1.6%$7.36$7.53$7.1751,609,035
$7.40-0.14-1.9%$7.45$7.60$7.091,512,884
$7.54-0.14-1.8%$7.73$7.75$7.3851,992,204
$7.68-0.02-0.3%$7.93$7.93$7.602,503,526
$7.70-0.16-2.0%$7.96$8.18$7.682,036,769
$7.86-0.16-2.0%$7.87$8.01$7.621,745,450
$8.02+0.50+6.6%$7.53$8.16$7.4952,146,613
$7.52+0.54+7.7%$7.02$7.62$7.021,936,351
$6.98-0.74-9.6%$6.85$7.57$6.803,211,753
$7.72+0.27+3.6%$7.73$7.89$7.283,619,529
$7.45+0.26+3.6%$7.33$7.75$7.331,903,718
$7.19-0.62-7.9%$7.81$7.99$7.1552,292,419
$7.81-0.65-7.7%$8.37$8.48$7.681,703,904
$8.46-0.04-0.5%$8.49$8.62$8.291,384,941
$8.50+0.24+2.9%$8.23$8.525$8.152,712,370
$8.26+0.68+9.0%$7.60$8.28$7.503,068,338
$7.58+0.26+3.6%$7.32$7.60$7.321,268,559
$7.32+0.25+3.5%$7.03$7.33$6.981,447,700
$7.07-0.50-6.6%$7.44$7.61$6.733,920,300
$7.57+0.37+5.1%$7.18$7.615$7.181,699,800
$7.20+0.21+3.0%$6.99$7.595$6.9852,022,500
$6.99+0.20+2.9%$6.79$7.02$6.691,349,400
$6.79-0.28-4.0%$7.05$7.08$6.7352,238,700
$7.07+0.52+7.9%$6.70$7.15$6.512,367,100
$6.55+0.02+0.3%$6.41$6.67$6.3342,742,500
$6.53-0.53-7.5%$6.95$7.06$6.524,326,200
$7.06-0.38-5.1%$7.38$7.381$6.951,253,200
$7.44+0.23+3.2%$7.25$7.52$7.172,304,500
$7.21-0.22-3.0%$7.31$7.37$7.013,593,800
$7.43-0.42-5.4%$7.65$7.73$7.224,272,700
$7.85-0.67-7.9%$8.54$8.74$7.7653,613,100
$8.52+0.62+7.8%$8.015$8.575$7.802,629,000
$7.90+0.40+5.3%$7.62$7.92$7.501,913,600
$7.50-0.16-2.1%$7.67$7.73$7.3254,340,000
$7.66+0.01+0.1%$7.65$7.75$7.533,606,300
$7.65+0.02+0.3%$7.52$7.70$7.4351,755,500
$7.63+0.03+0.4%$7.49$7.68$7.401,942,300
$7.60-0.05-0.7%$7.61$7.65$7.2451,930,300
$7.65+0.28+3.8%$7.35$7.76$7.312,392,700
$7.37-0.09-1.2%$7.42$7.48$7.131,549,300
$7.46+0.29+4.0%$7.18$7.49$6.9851,571,000
$7.17+0.20+2.9%$7.00$7.235$6.922,300,100
$6.97-0.30-4.1%$7.20$7.24$6.8252,518,400
$7.27+0.43+6.3%$6.98$7.515$6.983,446,200
$6.84-0.04-0.6%$6.90$7.089$6.783,080,900
$6.88+0.195+2.9%$6.68$7.00$6.632,676,800
$6.685+0.155+2.4%$6.53$6.81$6.532,260,100
$6.53-0.20-3.0%$6.84$6.91$6.4853,263,000
$6.73-0.22-3.2%$6.81$6.89$6.663,325,000
$6.95-0.24-3.3%$7.08$7.16$6.9252,206,700
$7.19-0.13-1.8%$7.30$7.32$7.102,272,700
$7.32-0.05-0.7%$7.25$7.435$7.171,552,100
$7.37-0.01-0.1%$7.38$7.455$7.2122,908,000
$7.38+0.08+1.1%$7.30$7.605$7.273,668,100
$7.30-0.34-4.5%$7.58$7.59$7.282,698,300
$7.64-0.04-0.5%$7.71$7.725$7.525,318,000
$7.68-0.69-8.2%$8.12$8.175$7.6455,563,000
$8.37-0.53-6.0%$8.76$8.98$8.3253,171,000
$8.90-0.10-1.1%$8.85$9.42$8.685,537,600
$9.00+0.57+6.8%$8.53$9.06$8.345,695,900
$8.43-0.21-2.4%$8.59$8.615$8.136,964,200
$8.64+0.35+4.2%$8.28$8.87$8.209,390,900
$8.29+1.07+14.8%$7.44$8.378$7.3813,145,900
Ticker
NASDAQ:MRVI
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Maravai LifeSciences Holdings, Inc. news

Maravai LifeSciences Holdings, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
13 in the last 12 months · 131 in all · newest Nov 4, 2026 · oldest 2020
Calls
18 calls with a replay · 18 with a transcript · latest Nov 4, 2026
Decks
26 decks · latest Nov 4, 2026

Where Maravai LifeSciences Holdings, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MRVI · Home listing · This pageNASDAQUnited StatesUSD
BMV:MRVIBMVMexicoMXN
LS Exchange:A2QHK8LS ExchangeGermanyEUR
Lang & Schwarz:A2QHK8Lang & SchwarzGermanyEUR
Stuttgart:MARStuttgartGermanyEUR
Frankfurt:MARFrankfurtGermanyEUR
BOATS:MRVIBOATSUnited StatesUSD
Dusseldorf:MARDusseldorfGermanyEUR
Tradegate:MARTradegateGermanyEUR
BIVA:MRVIBIVAMexicoMXN

Valuation

EV/sales 5.2× against a median of 3.8×: 7th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.11B USD
P/E
Loss
EV/sales
5.2×
EV/EBITDA
Negative EBITDA
Price/book
5.3×
Gross margin
39.1%
Operating margin
−45.4%
Net margin
−30.8%
Debt to equity
0.8×
Beta vs S&P 500
1.56

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Maravai LifeSciences Holdings, Inc. · NASDAQ:MRVIUS$1.04BUS$1.11Bn/a5.2×n/a5.3×−30.8%0.8×1.56
Vcanbio Cell & Gene Engineering Corp., Ltd. Class A · SSE:600645US$1.06BUS$786.1M62.8×3.8×n/a1.9×8.2%0.0×n/a
Beijing Strong Biotechnologies Inc Class A · SZSE:300406US$1.05BUS$1.13B28.0×5.5×n/a1.9×18.2%0.3×n/a
Freenome, Inc. · NASDAQ:FRNMUS$1.04BUS$863.3M9.5×n/an/a2.2×n/a0.0×n/a
Suzhou Novoprotein Scientific Co., Ltd. Class A · SSE:688137US$1.02BUS$909.1Mn/a38.0×n/a3.4×−60.8%0.0×n/a
Castle Biosciences, Inc. · NASDAQ:CSTLUS$1.01BUS$745.1Mn/a2.0×n/a2.1×−6.1%0.0×1.00
Guangzhou Wondfo Biotech Co., Ltd. Class A · SZSE:300482US$1.01BUS$785.0Mn/a2.7×n/a1.2×−3.2%0.0×n/a
St Pharm Co., Ltd. · KRX:237690US$992.7MUS$866.0M17.4×3.0×11.1×2.1×19.9%0.0×n/a
Daan Gene Co., Ltd. Class A · SZSE:002030US$990.1MUS$810.9Mn/a7.0×n/a0.9×−95.7%0.0×n/a
Amoy Diagnostics Co., Ltd. Class A · SZSE:300685US$967.3MUS$801.3M18.8×4.4×n/a3.3×28.5%0.1×n/a
Novogene Co., Ltd. Class A · SSE:688315US$949.6MUS$685.6M43.1×2.0×n/a2.3×6.4%0.0×n/a
Median of the othersUS$1.01BUS$806.1M23.4×3.8×11.1×2.1×6.4%0.0×1.00

Forecasts

6 strong buy · 3 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
9.64 USD · Analysts' mean
EPS, year to Dec 2026
-0.070 · 9 analysts
Revenue, year to Dec 2026
214.3M · 9 analysts

Team and board

Officers

OfficerRole
Bernd BrustChief Executive Officer and Board Member
Raj AsarpotaEVP, Chief Financial Officer
Kurt OreshackEVP, Secretary and General Counsel
Andrew MurphyVice President, General Manager, Glen Research
Chad DeckerSenior Vice President, Sales, TriLink and Alphazyme
Chanfeng ZhaoSenior Vice President, Chief Scientific Officer
Christine DolanEVP, Biologics Safety Testing
Davide De LucreziaSenior Vice President, Digital Innovation, Products & Marketing
Elie ChaayaSenior Vice President, TriLink Global Operations
Judy SoleckiChief Human Resources Officer

Board

DirectorRole
Andy EckertChairman of the Board
Bernd BrustChief Executive Officer and Board Member
Constantine MihasDirector
Gregory T. LucierDirector

Events

Next results
Feb 24, 2027 (expected)

Calls

CallWhenStatus
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q3 2026 Earnings CallWed, Nov 04, 2026 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q2 2026 Earnings CallThu, Aug 06, 2026 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2026 Earnings CallThu, May 07, 2026 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q4 2025 Earnings CallWed, Feb 25, 2026 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q2 2025 Earnings CallMon, Aug 11, 2025 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2025 Earnings CallMon, May 12, 2025 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q3 2024 Earnings CallThu, Nov 07, 2024 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q2 2024 Earnings CallWed, Aug 07, 2024 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2024 Earnings CallWed, May 08, 2024 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q4 2023 Earnings CallThu, Feb 22, 2024 · 5:00 PM ETReplay
All 18 calls
CallWhenStatus
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:05 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2023 Earnings CallMon, May 08, 2023 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q4 2022 Earnings CallWed, Feb 22, 2023 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q3 2022 Earnings CallWed, Nov 02, 2022 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2022 Earnings CallThu, May 05, 2022 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q4 2021 Earnings CallWed, Feb 23, 2022 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q3 2021 Earnings CallWed, Nov 10, 2021 · 5:00 PM ETReplay
Maravai LifeSciences Holdings (NASDAQ:MRVI) Q1 2021 Earnings CallMon, May 10, 2021 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−9.6%
Q2 2026Aug 6, 2026 · After close−0.3%
Q1 2026May 7, 2026 · After close+23.1%
Q4 2025Feb 25, 2026+14.1%
Q3 2025Nov 6, 2025 · After close−0.7%
Q2 2025Aug 11, 2025 · After close+30.6%
Q1 2025May 12, 2025 · After close−2.8%
Q4 2024Feb 20, 2025 · After close+4.0%
Q3 2024Nov 7, 2024 · After close−35.3%
Q2 2024Aug 7, 2024 · After close−6.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+11.2%
Q4 2023Feb 22, 2024 · After close+63.6%
Q3 2023Nov 7, 2023 · After close−31.7%
Q2 2023Aug 7, 2023 · After close+0.7%
Q1 2023May 8, 2023 · After close−13.0%
Q4 2022Feb 22, 2023 · After close+8.2%
Q3 2022Nov 2, 2022 · After close−5.5%
Q2 2022Aug 4, 2022 · After close+2.3%
Q1 2022May 5, 2022 · After close+13.4%
Q4 2021Feb 23, 2022 · After close−1.0%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings28 slidesNov 4, 2026
Investor Presentation (November 2026)Investor deck27 slidesNovember 2026
Investor Presentation (September 2026)Investor deck27 slidesSeptember 2026
Q2 2026 Earnings PresentationEarnings26 slidesAug 6, 2026
Q1 2026 Earnings PresentationEarnings25 slidesMay 7, 2026
Q4 2025 Earnings PresentationEarnings24 slidesFeb 25, 2026
Q3 2025 Earnings PresentationEarnings22 slidesNov 6, 2025
Q2 2025 Earnings PresentationEarnings21 slidesAug 11, 2025
Q1 2025 Earnings PresentationEarnings25 slidesMay 12, 2025
Q4 2024 Earnings PresentationEarnings25 slidesMar 20, 2025
All 26 decks
DeckKindSlidesDate
Q3 2024 Earnings PresentationEarnings24 slidesNov 7, 2024
Q2 2024 Earnings PresentationEarnings30 slidesAug 7, 2024
Q1 2024 Earnings PresentationEarnings25 slidesMay 8, 2024
Q4 2023 Earnings PresentationEarnings31 slidesFeb 22, 2024
Q3 2023 Earnings PresentationEarnings26 slidesNov 7, 2023
Investor Day (September 2023)Investor day152 slidesSeptember 2023
Investor Day (September 2023)Investor day150 slidesSeptember 2023
Q2 2023 Earnings PresentationEarnings25 slidesAug 7, 2023
Q1 2023 Earnings PresentationEarnings31 slidesMay 8, 2023
Q4 2022 Earnings PresentationEarnings33 slidesFeb 22, 2023
Q3 2022 Earnings PresentationEarnings26 slidesNov 2, 2022
Q2 2022 Earnings PresentationEarnings29 slidesAug 4, 2022
Q1 2022 Earnings PresentationEarnings26 slidesMay 5, 2022
Q4 2021 Earnings PresentationEarnings27 slidesFeb 23, 2022
Investor Day (January 2022)Investor day74 slidesJan 28, 2022
Q3 2021 Earnings PresentationEarnings28 slidesNov 10, 2021

Open Decks

IPO

Priced at US$27.00 a share on Nov 19, 2020.

Price
US$27.00 a share
Shares offered
60,000,000 shares of Class A common stock
Offering size
US$1.62 billion
Underwriters' option
Up to 9,000,000 more shares
Underwriters
MORGAN STANLEY, JEFFERIES, GOLDMAN SACHS & CO. LLC, BOFA SECURITIES, CREDIT SUISSE, UBS INVESTMENT BANK, BAIRD, WILLIAM BLAIR, STIFEL, KEYBANC CAPITAL MARKETS, ACADEMY SECURITIES, LOOP CAPITAL MARKETS, PENSERRA SECURITIES LLC, TIGRESS FINANCIAL PARTNERS · In the order on the cover
Shares delivered
On or about Nov 24, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceSep 8, 2020
Filed publiclyOct 29, 2020
Amended twiceNewest Nov 13, 2020
Shares registered with an exchangeNov 19, 2020
Declared effective by the SECNov 19, 2020
Final prospectus, with the priceNov 23, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Nov 23, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue185.7M259.2M288.9M883.0M799.2M284.1M143.1M123.8M
Cost of revenue151.8M150.9M148.7M169.0M140.6M79.6M66.8M60.8M
Gross profit34.0M108.3M140.2M714.0M658.7M204.4M76.3M63.1M
Research and development17.4M19.2M17.3M18.4M15.2M9.30M3.63M4.50M
Selling, general and administrative145.1M161.8M151.4M129.3M100.1M94.2M48.4M41.2M
Operating income-215.3M-235.6M-31.6M574.2M554.6M119.9M24.0M16.4M
Depreciation and amortization23.6M20.9M12.9M7.57M6.41M5.59M3.81M22.3M
EBITDA-191.7M-214.8M-18.8M581.8M561.1M125.5M27.8M38.8M
Interest expense27.0M47.7M45.9M20.4M30.3M30.7M30.0M27.4M
Income before tax-235.0M-261.5M617.7M551.5M530.8M81.7M-5.85M-16.5M
Income tax-4.21M-1.86M756.1M60.8M61.5M2.88M-652.0K417.0K
Net income-130.8M-144.8M-119.0M220.2M182.0M89.0M-4.47M-17.7M
Earnings per share, basic-0.90-1.05-0.901.671.597.43-0.03-0.20
Earnings per share, diluted-0.90-1.05-0.901.671.562.36-0.03

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents216.9M322.4M575.0M632.1M551.3M236.2M24.7M21.9M
Receivables25.5M38.5M54.6M138.6M117.5M51.0M18.0M16.0M
Inventory40.5M50.1M51.4M43.2M51.6M33.3M14.2M14.3M
Current assets296.3M429.1M699.9M847.9M740.0M331.6M60.6M53.8M
Property, plant and equipment151.5M164.5M162.9M52.7M46.3M101.3M94.3M42.6M
Goodwill129.4M159.9M326.0M283.7M152.8M224.3M224.3M224.3M
Total assets770.6M1.01B1.49B2.28B1.92B1.27B577.8M539.7M
Accounts payable2.91M12.0M10.7M5.99M8.15M8.17M7.48M3.60M
Current liabilities44.9M57.0M87.5M110.1M93.8M130.8M29.6M35.9M
Long-term debt286.3M290.5M518.7M522.0M524.6M528.6M334.8M335.6M
Total debt291.8M295.9M524.1M527.4M530.6M534.6M390.2M339.9M
Total liabilities397.9M431.0M697.6M1.38B1.37B1.12B433.2M391.7M
Shareholders' equity212.4M325.3M416.8M545.2M315.5M88.5M144.6M144.4M
Shares outstanding145.1M137.9M131.9M131.7M122.0M96.6M96.6M89.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-57.6M7.46M126.2M536.0M368.6M152.2M24.1M-186.0K
Capital spending-13.1M-29.7M-65.6M-17.1M-14.8M-25.4M-17.1M-3.61M
Free cash flow-70.7M-22.2M60.7M518.9M353.7M126.8M6.97M-3.80M
Cash from investing-31.4M-24.3M-122.3M-267.6M105.7M6.07M-17.1M-3.45M
Cash from financing-16.5M-235.7M-61.1M-187.5M-159.0M53.2M-4.17M-9.17M
Dividends paid-153.5M-609.3M-97.1M-52.1M
Share buybacks-2.08M-20.0K00-33.7M0-9.00K
Change in cash-105.5M-252.6M-57.2M80.9M315.1M211.5M2.83M-12.9M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 12, 2026Insider tradeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026Current reportSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipOct 9, 2026Insider tradeSEC
4 · Change in ownershipOct 1, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeSep 29, 2026Big-stake noticeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 11, 2026Insider tradeSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
4 · Change in ownershipAug 3, 2026Insider tradeSEC
4 · Change in ownershipJul 10, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJun 29, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJun 23, 2026Big-stake noticeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 10, 2026Other filingsSEC
144 · Notice of proposed saleJun 9, 2026Other filingsSEC
8-K · Current reportJun 3, 2026Material contractSEC
8-K · Current reportMay 29, 2026Meeting outcomeSEC
4/A · Change in ownership, amendedMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
DEFA14A · Additional proxy materialApr 27, 2026Meeting noticeSEC
ARS · Annual report to shareholdersApr 24, 2026Annual reportSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
144 · Notice of proposed saleDec 23, 2025Other filingsSEC
144 · Notice of proposed saleDec 19, 2025Other filingsSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 31, 2025Big-stake noticeSEC
8-K · Current reportOct 27, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
8-K · Current reportAug 11, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2025Big-stake noticeSEC
8-K · Current reportJul 18, 2025Current reportSEC
4 · Change in ownershipJul 16, 2025Insider tradeSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJun 30, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 30, 2025Insider tradeSEC
8-K · Current reportJun 25, 2025Management or board changeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 10, 2025Insider tradeSEC
8-K · Current reportJun 9, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 29, 2025Big-stake noticeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
8-K · Current reportMay 28, 2025Meeting outcomeSEC
S-8 · Registration statement for employee plansMay 12, 2025Offer documentSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
8-K · Current reportMay 12, 2025ResultsSEC
ARS · Annual report to shareholdersApr 18, 2025Annual reportSEC
DEF 14A · Proxy statementApr 18, 2025Meeting noticeSEC
8-K · Current reportMar 20, 2025Current reportSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
10-K · Annual reportMar 18, 2025Annual reportSEC
8-K · Current reportMar 18, 2025ResultsSEC
NT 10-K · Late filing noticeMar 4, 2025Explanation requestSEC
8-K · Current reportFeb 24, 2025ResultsSEC
UPLOAD · Letter from the SECFeb 20, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 19, 2025Other filingsSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipJan 31, 2025Insider tradeSEC
144 · Notice of proposed saleJan 31, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 28, 2025Big-stake noticeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
8-K · Current reportJan 8, 2025ResultsSEC
8-K · Current reportDec 18, 2024Current reportSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 9, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 5, 2024Insider tradeSEC
8-K · Current reportDec 5, 2024Management or board changeSEC
4 · Change in ownershipNov 18, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
4 · Change in ownershipNov 14, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
SC 13G · Big-stake noticeNov 8, 2024Big-stake noticeSEC
8-K · Current reportNov 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedOct 29, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeOct 22, 2024Big-stake noticeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
UPLOAD · Letter from the SECSep 17, 2024Other filingsSEC
8-K · Current reportSep 12, 2024Material contractSEC
CORRESP · Letter to the SECAug 16, 2024Other filingsSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
8-K · Current reportJul 29, 2024Management or board changeSEC
UPLOAD · Letter from the SECJul 19, 2024Other filingsSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
CORRESP · Letter to the SECJun 24, 2024Other filingsSEC
UPLOAD · Letter from the SECJun 12, 2024Other filingsSEC
8-K · Current reportJun 11, 2024Management or board changeSEC
SC 13G · Big-stake noticeJun 10, 2024Big-stake noticeSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
144 · Notice of proposed saleMay 28, 2024Other filingsSEC
144 · Notice of proposed saleMay 28, 2024Other filingsSEC
8-K · Current reportMay 28, 2024Meeting outcomeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
SC 13G · Big-stake noticeMay 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
ARS · Annual report to shareholdersApr 25, 2024Annual reportSEC
DEF 14A · Proxy statementApr 25, 2024Meeting noticeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
10-K · Annual reportFeb 29, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 28, 2024Big-stake noticeSEC
8-K · Current reportFeb 22, 2024ResultsSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
SC 13G · Big-stake noticeFeb 15, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC

This page holds 200 of 426 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Maravai LifeSciences Holdings, Inc.’s releases

Common shares
148,989,545
Fully diluted
148,989,545

Fully diluted

LineShares
Common shares148,989,545

Share count over time

CountShares
Nov 22, 2026148,989,545

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Gtcr LLC20.2M13.5%US$154MNo changeNov 13, 2026
BlackRock10.6M7.1%US$80.9M+591KNov 13, 2026
Millennium7.62M5.1%US$58.4M+1.11MNov 16, 2026
Vanguard7.61M5.1%US$58.3M+345KNov 13, 2026
Fidelity6.9M4.6%US$52.9M+6.87MNov 10, 2026
Ameriprise5.84M3.9%US$44.7M+5.63MNov 16, 2026
Braidwell LP5.5M3.7%US$42.2M−3.2MNov 16, 2026
Renaissance Technologies3.99M2.7%US$30.5M−619KNov 12, 2026
12 West Capital Management LP3.8M2.6%US$29.1M−3.26MNov 16, 2026
Wellington3.66M2.5%US$28.1MNewNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Nuveen3.49M2.3%US$26.7M+634KNov 10, 2026
First Eagle Investment Management, LLC3.28M2.2%US$25.1M−4.06MNov 10, 2026
Geode Capital3.12M2.1%US$23.9M−11,822Nov 6, 2026
State Street3.06M2.1%US$23.4M+155KNov 12, 2026
Qube Research & Technologies Ltd2.91M2.0%US$22.3M+2.16MNov 13, 2026
Morgan Stanley2.71M1.8%US$20.8M+803KNov 13, 2026
Point72 Asset Management, L.P.2.51M1.7%US$19.3M+509KNov 16, 2026
Arrowstreet Capital, Limited Partnership2.49M1.7%US$19.1M+977KNov 13, 2026
Two Sigma2.2M1.5%US$16.8M−59,231Nov 16, 2026
Goldman Sachs2.04M1.4%US$15.7M+402KNov 16, 2026
Marshall Wace, LLP2.03M1.4%US$15.6M+563KNov 13, 2026
Citadel1.86M1.2%US$14.2M−265KNov 16, 2026
Systematic Financial Management LP1.84M1.2%US$14.1M+173KNov 16, 2026
General American Investors Co Inc1.72M1.2%US$13.1MNo changeNov 2, 2026
Royce & Associates LP1.7M1.1%US$13.1M−105KNov 9, 2026
Driehaus Capital Management LLC1.59M1.1%US$12.1MNewNov 16, 2026
Hillsdale Investment Management Inc.1.52M1.0%US$11.7M−159KNov 12, 2026
BNP Paribas1.41M0.95%US$10.8M+622KNov 12, 2026
Hrt Financial LP1.37M0.92%US$10.5M+303KNov 13, 2026
Dimensional1.34M0.90%US$10.3M−16,878Nov 4, 2026
ArrowMark Colorado Holdings LLC1.32M0.89%US$10.1M+50,000Nov 16, 2026
Fred Alger Management, LLC1.14M0.77%US$8.74MNewNov 16, 2026
Schwab1.1M0.74%US$8.43M+92,743Nov 16, 2026
Federated Hermes, Inc.1.09M0.73%US$8.38MNewNov 12, 2026
Philosophy Capital Management LLC1.09M0.73%US$8.36M−808KNov 16, 2026
Northern Trust1.07M0.72%US$8.19M+68,877Nov 16, 2026
Prudential Financial Inc1.04M0.70%US$7.97M−1.11MNov 16, 2026
Tudor Investment Corp Et Al1.03M0.69%US$7.89M−820KNov 16, 2026
First Pacific Advisors, LP885K0.59%US$6.78MNo changeNov 12, 2026
Kennedy Capital Management LLC827K0.55%US$6.33M−281KNov 13, 2026
Verition Fund Management LLC760K0.51%US$5.82M−17,738Nov 13, 2026
Jacobs Levy Equity Management, Inc710K0.48%US$5.44M−318KNov 16, 2026
Healthcare Of Ontario Pension Plan Trust Fund687K0.46%US$5.26MNewNov 13, 2026
Select Equity Group, L.P.674K0.45%US$5.16MNewNov 16, 2026
Monaco Asset Management SAM647K0.43%US$4.96M−1.58MNov 9, 2026
ExodusPoint Capital Management, LP614K0.41%US$4.7MNewNov 16, 2026
Informed Momentum Co LLC572K0.38%US$4.38MNewNov 16, 2026
Pier Capital, LLC555K0.37%US$4.25MNewNov 13, 2026
Bank of America522K0.35%US$4M−7,916Nov 16, 2026
UBS512K0.34%US$3.92M+251KNov 16, 2026

This page holds 50 of 194 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund3.71M2.5%US$23.1M−217KJun 30, 2026
First Eagle Small Cap Opportunity Fund3.24M2.2%US$21.3M+878KJul 31, 2026
iShares Russell 2000 ETF2.97M2.0%US$18.5M+305KJun 30, 2026
Nuveen Quant Small Cap Equity Fund1.6M1.1%US$10.5MNewJul 31, 2026
Vanguard Extended Market Index Fund1.46M0.98%US$9.08M+52,978Jun 30, 2026
Meridian Contrarian Fund1.27M0.86%US$7.96MNewJun 30, 2026
Fidelity Small Cap Growth Fund1.26M0.85%US$8.31MNewJul 31, 2026
Fidelity Small Cap Index Fund1.23M0.83%US$8.11M+153KJul 31, 2026
iShares Russell 2000 Value ETF1.02M0.68%US$6.36M+84,999Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account949K0.64%US$5.92MNewJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
iShares Biotechnology ETF741K0.50%US$4.63M−17,834Jun 30, 2026
Fidelity Small Cap Growth K6 Fund660K0.44%US$4.33MNewJul 31, 2026
Fidelity Extended Market Index Fund638K0.43%US$3.06M+91,520May 31, 2026
Schwab U.S. Small-Cap ETF589K0.40%US$2.83M−9,592May 31, 2026
Vanguard Russell 2000 Index Fund560K0.38%US$2.69M+17,646May 31, 2026
Royce Micro-Cap Fund508K0.34%US$3.17MNo changeJun 30, 2026
Federated Hermes MDT Small Cap Core Fund478K0.32%US$3.14MNewJul 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF456K0.31%US$2.85MNewJun 30, 2026
Nuveen Quant Small/Mid Cap Equity Fund434K0.29%US$2.85MNewJul 31, 2026
JPMorgan U.S. Small Company Fund412K0.28%US$2.57MNewJun 30, 2026
JPMorgan Small Cap Value Fund344K0.23%US$2.14MNewJun 30, 2026
Vanguard Health Care Index Fund324K0.22%US$1.55M−2,747May 31, 2026
Dimensional U.S. Small Cap ETF286K0.19%US$1.88M−171KJul 31, 2026
U.S. Small Cap Portfolio279K0.19%US$1.84MNo changeJul 31, 2026
Schwab Small-Cap Index Fund273K0.18%US$1.8M+30,948Jul 31, 2026
U.S. Micro Cap Portfolio260K0.17%US$1.71M+5,963Jul 31, 2026
AST PGIM Aggressive Multi-Asset Portfolio240K0.16%US$1.5MNewJun 30, 2026
Fidelity Total Market Index Fund230K0.15%US$1.11MNo changeMay 31, 2026
Master Small Cap Index Series211K0.14%US$1.32M+20,307Jun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF208K0.14%US$1.3M+61,105Jun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF203K0.14%US$1.34M−74,287Jul 31, 2026
Multi-Manager Small Cap Equity Strategies Fund194K0.13%US$929KNewMay 31, 2026
PGIM Quant Solutions Large-Cap Core Fund188K0.13%US$1.24MNewJul 31, 2026
Fidelity Series Total Market Index Fund187K0.13%US$898K+8,403May 31, 2026
Royce Capital Fund - Micro-Cap Portfolio163K0.11%US$1.02MNo changeJun 30, 2026
NVIT Multi-Manager Small Company Fund158K0.11%US$988K+52,400Jun 30, 2026
Fidelity Small Cap Value Index Fund158K0.11%US$984K+21,559Jun 30, 2026
Nuveen Small Cap Blend Index Fund150K0.10%US$987K+12,752Jul 31, 2026
PGIM Quant Solutions Small-Cap Value Fund124K0.08%US$811KNewJul 31, 2026
EQ/2000 Managed Volatility Portfolio123K0.08%US$767K+4,153Jun 30, 2026
SIMT Tax-Managed Small/Mid Cap Fund104K0.07%US$649KNewJun 30, 2026
LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund97,1860.07%US$606KNewJun 30, 2026
Fidelity Nasdaq Composite Index Fund89,6310.06%US$430KNo changeMay 31, 2026
LVIP JPMorgan Small Cap Core Fund89,0510.06%US$556KNewJun 30, 2026
Vanguard Russell 2000 Value Index Fund87,7240.06%US$421K+7,284May 31, 2026
JPMorgan Small Cap Value Portfolio86,5420.06%US$540KNewJun 30, 2026
Nuveen Equity Index Fund85,9890.06%US$565KNo changeJul 31, 2026
NVIT Small Cap Value Fund81,8980.05%US$511K+40,300Jun 30, 2026
Schwab U.S. Broad Market ETF81,2900.05%US$390K+958May 31, 2026
LVIP State Street Small-Cap Index Fund80,8000.05%US$504K+4,500Jun 30, 2026

This page holds 50 of 154 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Oreshack Kurt
Officer: General Counsel
Sale25,000USD 5.10US$127KJun 10, 2026
Oreshack Kurt
Officer: General Counsel
Sale25,000USD 5.06US$126KJun 9, 2026

Big stakes

HolderStakeSharesDate
BlackRock, Inc.5.90%8.58MSep 30, 2025
Millennium Management LLC5.20%7.77MSep 22, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gregory T. Lucier
Other companies: Avantor, Inc. (Director · Since at least Oct 3, 2025); Dentsply Sirona Inc. (Non-Executive Chairman of the Board · Since at least May 22, 2019); Berkeley Lights Inc (Director · Jul 16, 2020 – May 26, 2022 · Past); Invuity Inc (Director · Jun 11, 2015 – Oct 23, 2018 · Past); Catalent Inc (Director · Apr 30, 2015 – Dec 18, 2024 · Past); NuVasive Inc (Director · Dec 4, 2013 – May 18, 2021 · Past); CareFusion Corp (Director · Aug 31, 2009 – Mar 17, 2015 · Past)
Director · Since at least Nov 19, 2020
Susannah Gray
Other companies: AnaptysBio, Inc. (Member of the Audit Committee · Since at least Mar 26, 2026); Theravance Biopharma, Inc. (Director · Since at least Feb 26, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Apria Inc (Director · May 4, 2021 – Mar 29, 2022 · Past); Morphic Holding Inc (Director · Apr 27, 2021 – Aug 16, 2024 · Past)
Director · Since at least Nov 19, 2020
Jessica Hopfield
Other companies: Editas Medicine, Inc. (Chair · Since at least Feb 14, 2018); Insulet Corporation (Director · Since at least Jul 27, 2015); Berkeley Lights Inc (Director · Dec 15, 2021 – May 26, 2022 · Past); Radius Health, Inc. (Director · Jan 24, 2019 – Feb 20, 2020 · Past)
Director · Since at least Nov 19, 2020
Anat Ashkenazi
Other companies: Alphabet Inc (Google) Class C (SVP, Chief Financial Officer · Since at least Jul 31, 2024); Eli Lilly and Company (EVP & CFO · Feb 8, 2021 – Feb 12, 2024 · Past); Varian Medical Systems Inc (Director · Dec 1, 2018 – Apr 15, 2021 · Past)
Director · Nov 19, 2020 – May 23, 2024 · Past
John DeFord
Other companies: Globus Medical, Inc. (Director · Since at least Sep 1, 2023); Nordson Corporation (Chairman, Chief Executive Officer and President · Since at least Nov 23, 2020); NuVasive Inc (Director · Feb 26, 2018 – Sep 1, 2023 · Past)
Director · Since at least Jul 20, 2023
Rajesh Asarpota
Other companies: Profusa, Inc. (Director · Since at least Jul 11, 2025); NuVasive Inc (CFO · Sep 1, 2017 – Mar 1, 2019 · Past); Questcor Pharmaceuticals Inc (Sr. VP., CFO and PAO · Feb 17, 2014 – Aug 14, 2014 · Past)
Chief Financial Officer · Since at least Jun 30, 2025
R. Andrew Eckert
Other companies: Becton, Dickinson and Company (Director · Since at least Sep 26, 2016); Fortrea Holdings Inc. (Director · Jun 29, 2023 – Feb 21, 2025 · Past); Varian Medical Systems Inc (Director · Feb 3, 2012 – Feb 11, 2021 · Past)
Director · Since at least Dec 5, 2024
Carl Hull
Other companies: Ortho Clinical Diagnostics Holdings plc (Director · Jan 27, 2021 – May 27, 2022 · Past); Hologic Inc (SVP and GM of Diagnostics · Aug 1, 2012 – Feb 1, 2013 · Past)
See Remarks, Director · Nov 19, 2020 – Nov 11, 2024 · Past
Christine Dolan
Other companies: Catalent Inc (SVP - Product Development · Sep 8, 2016 – Aug 29, 2017 · Past)
EVP, Biologics Safety Testing · Since at least Nov 19, 2020
Constantine Mihas
Other companies: Sotera Health Company (Director · Nov 20, 2020 – May 22, 2025 · Past)
Director · Since at least Nov 19, 2020
All 33 people
PersonSeat
Kevin Herde
Other companies: Sorrento Therapeutics, Inc. (Executive VP and CFO · Apr 5, 2016 – Feb 3, 2017 · Past)
Chief Financial Officer · Nov 19, 2020 – May 15, 2025 · Past
Peter Michael Leddy
Other companies: NuVasive Inc (EVP, People and Culture · Jul 27, 2011 – Aug 1, 2018 · Past)
See Remarks · Since at least Jun 27, 2022
Robert B Hance
Other companies: Abbott Laboratories (Senior Vice President · Dec 11, 2006 – Feb 29, 2012 · Past)
Director · Nov 19, 2020 – Nov 19, 2021 · Past
Sean Laurence Cunningham
Other companies: Sotera Health Company (Director · Since at least Nov 20, 2020)
Director · Since at least Nov 19, 2020
William E Martin III
Other companies: Azenta, Inc. (President Multiomics · Since at least Apr 6, 2026)
Chief Executive Officer · Sep 30, 2022 – Mar 17, 2025 · Past
Andrew BurchSee Remarks · Mar 31, 2023 – Jan 15, 2025 · Past
Andrew MurphyVice President, General Manager, Glen Research · Since at least Nov 4, 2026
Andy EckertChairman of the Board · Since at least May 28, 2026
Benjamin James DavermanDirector · Since at least Nov 19, 2020
Bernd BrustChief Executive Officer and Board Member · Since at least Jun 8, 2025
Brian NeelSee Remarks · Nov 19, 2020 – Feb 15, 2023 · Past
Chad DeckerSenior Vice President, Sales, TriLink and Alphazyme · Since at least Jun 16, 2026
Chanfeng ZhaoSenior Vice President, Chief Scientific Officer · Since at least Jul 20, 2026
Davide De LucreziaSenior Vice President, Digital Innovation, Products & Marketing · Since at least Feb 24, 2025
Elie ChaayaSenior Vice President, TriLink Global Operations · Since at least Nov 4, 2026
Eric TardifPresident · Nov 19, 2020 – Nov 19, 2020 · Past
Judy SoleckiChief Human Resources Officer · Since at least Nov 4, 2026
Kurt OreshackEVP, Secretary and General Counsel · Since at least Nov 19, 2020
Lisa SellersSee Remarks · Nov 19, 2020 – Nov 24, 2020 · Past
Luke Joseph MarkerDirector · Since at least Nov 19, 2020
Murali PrahaladDirector · Since at least Nov 19, 2020
Raj AsarpotaEVP, Chief Financial Officer · Since at least Oct 29, 2026
Rebecca BuzzeoSee Remarks · Mar 31, 2023 – Mar 17, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Maravai LifeSciences Holdings, Inc.